Back

Lipoprotein(a) cardiovascular disease risk not captured by low density lipoprotein cholesterol and apolipoprotein B

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Lipids as risk factor for heart disease Lipids ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Peter Thomas

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

7 More presentations in this session

Presentation thumbnail
Participation rate and yield of indirect cascade genetic screening for familial hypercholesterolemia using a web-based communication platform (CATCH): a randomized multicenter implementation trial
Assistant Professor D. Nanchen (Lausanne, CH)
Abstract Slides Video
Presentation thumbnail
Burden and sociodemographic disparities in cardiovascular mortality rates associated with hypercholesterolemia in united states: a nationwide county-level analysis from 2010 to 2019
Doctor S. Abohashem (Boston, US)
Abstract Slides Video
Presentation thumbnail
Remnant cholesterol lowering in cardiovascular disease risk reduction in statin trials: meta-regression analyses
Doctor A. Nordestgaard (Boston, US)
Abstract Slides Video
Presentation thumbnail
Remnant cholesterol and cardiovascular and all-cause mortality in Korean adults
Professor B. Kim (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Impact of measured or calculated small dense LDL cholesterol compared with apolipoprotein B or non-HDL cholesterol for long-term secondary prevention in patients with stable coronary artery disease
Professor S. Koba (Tokyo, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Lipids as risk factor for heart disease

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Elevated Lp(a) in primary and secondary prevention in Greece: prevalence and clinical relevance
thumbnail
Congress Presentation
Lipoprotein(a) measurements identify patients with elevated likelihood of obstructive coronary artery disease despite very low or low clinical likelihood
thumbnail
Congress Presentation
Study of lipoprotein(a) and its impact on atherosclerotic cardiovascular disease: design, rationale, and first results of the Zabrze-Lip(a)R Registry

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources